CD8+ T cells are the key undertakers of anti-tumor immunity, which will further proliferate and differentiate into effective cytotoxic cells with specific cancer killing ability after stimulated by tumor antigens and cytokines secreted by Th1 cells. Here, CD8A is linked to neoplasm.